Virus protease: Difference between revisions
From Proteopedia
Jump to navigationJump to search
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
''' | <StructureSection load='' size='350' side='right' caption='Structure of human rhinovirus 3C protease complex with inhibitor (PDB entry [[1cqq]])' scene='55/554890/Cv/1'> | ||
__TOC__ | |||
== Function == | |||
'''3C protease''' (3CP) is a virus cysteine protease which has essential role in viral replication. 3CP cleaves the precursor viral polyprotein to produce functional proteins and enzymes.<ref>PMID:17305557</ref> For more details on Foot and Mouth Disease virus 3C protease see [[FMDV 3C]]. | |||
== Disease == | |||
3CP is an attractive target for therapeutic agents for treatment of diseases caused by the common cold virus. Coxsakievirus causes the human diseases myocarditis and pericarditis. | |||
== Structural highlights == | |||
3CP - a Cys protease fold is similar to that of trypsin-like serine proteases. The <scene name='55/554890/Cv/6'>active site triad contains Cys147, His40 and Glu71</scene> (PDB entry [[1cqq]]).<ref>PMID:10500114</ref> <scene name='55/554890/Cv/5'>Whole binding site</scene>. | |||
See also<br /> | See also<br /> | ||
| Line 99: | Line 108: | ||
*'''Foot-and-Mouth Disease virus protease''' | *'''Foot-and-Mouth Disease virus protease''' | ||
**[[2bhg]] – FMDV | **[[2bhg]] – FMDV residues 1650-1857 (mutant) – Foot-and-mouth disease virus | ||
*'''Infectious Bronchitis virus protease''' | *'''Infectious Bronchitis virus protease''' | ||
Revision as of 16:29, 8 October 2018
| ||||||||||||
3D Structures of Virus proteases
Updated on 08-October-2018
- Simian Immunodeficiency virus protease See Human Immunodeficiency Virus
- Xenotropic murine leukemia virus protease
- HIV-1 protease – XMRV-PR P14
- HIV Protease Inhibitor Pharmacokinetics – XMRV-PR RNase H domain (mutant)
- HIV Protease Inhibitor Resistance Profile – XMRV-PR residues 533-657 + inhibitor
- HIV Protease Resistance – XMRV-PR residues 533-657 + pepstatin
- Molecular Playground/Dengue Virus Protease – XMRV-PR residues 533-657 + amprenavir
- HIV-1 protease – XMRV-PR P14
- Human T-cell leukemia virus protease
- Viability of a drug-resistant HIV-1 protease mutant – HTLV-PV + peptide
- Molecular Playground/Dengue Virus Protease, 3liq, 3lit, 3liv, 3lix, 3liy, 4ydg, 4ydf – HTLV-PV (mutant) + inhibitor
- Viability of a drug-resistant HIV-1 protease mutant – HTLV-PV + peptide
- Rous sarcoma virus protease
- Human Cytomegalovirus protease
- Varicella-Zoster virus protease
- 1vzv - VZVP (mutant) – human herpes virus
- Equine infectious anemia virus protease
- Hepatitis A virus protease
- Hepatitis C virus protease
- Orf 17
- 3njq – hOrf 17 - human herpes virus 8
- Dengue virus protease
- 3u1i – DvNs2b + peptide – Dengue virus
- 3u1j – DvNs2b + BPTI
- 2fom - DvNs2b/DvNs3
- 4m9f, 4m9i, 4m9k, 4m9m, 3lkw - DvNs2b/DvNs3 (mutant)
- 4m9t - DvNs2b/DvNs3 (mutant) + inhibitor
- 2jlq – DvNs3 residues 1646-2092
- 2jlv – DvNs3 residues 1646-2092 + AMPPNP + RNA
- 2jlr – DvNs3 residues 1646-2092 + AMPPNP
- 2jls – DvNs3 residues 1646-2092 + ADP
- 2jlx, 2jly, 2jlz – DvNs3 residues 1646-2092 + ADP + RNA
- 2jlu, 2jlw – DvNs3 residues 1646-2092 + RNA
- 2vbc, 2whx, 2wzq – DvNs3 residues 1475-2092 + peptide inhibitor
- 2m9p, 2m9q – DvNs3 residues 1475-1648 + peptide inhibitor - NMR
- 3u1i – DvNs2b + peptide – Dengue virus
- Herpes simplex virus protease
- 1at3 – HSV II – human herpesvirus 2
- Foot-and-Mouth Disease virus protease
- 2bhg – FMDV residues 1650-1857 (mutant) – Foot-and-mouth disease virus
- Infectious Bronchitis virus protease
- Yellowtail ascites virus protease
- Pseudorabies virus protease
- 4cx8 – YAV – pseudorabies virus
- 4cx8 – YAV – pseudorabies virus
References
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, Alexander Berchansky, Jaime Prilusky, Joel L. Sussman